Trifecta Capital Advisors, LLC Abbott Laboratories Transaction History
Trifecta Capital Advisors, LLC
- $452 Billion
- Q2 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 212 shares of ABT stock, worth $24,104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212
Previous 212
-0.0%
Holding current value
$24,104
Previous $24.1 Million
8.58%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ABT
# of Institutions
3,134Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.46 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.16 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.51 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...